ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

VHIO-“la Caixa” Advanced Oncology Research Program: accelerating progress and pushing boundaries in precision oncology

14/02/2020|Comments Off on VHIO-“la Caixa” Advanced Oncology Research Program: accelerating progress and pushing boundaries in precision oncology

Advances and new horizons in the diagnosis and treatment of colorectal cancer

10/02/2020|Comments Off on Advances and new horizons in the diagnosis and treatment of colorectal cancer

World Cancer Day 2020: International survey reveals unacceptable cancer awareness divide

04/02/2020|Comments Off on World Cancer Day 2020: International survey reveals unacceptable cancer awareness divide

World Cancer Day’s call to act for a cancer-free world: what will you pledge to help reduce the global burden of disease?

03/02/2020|Comments Off on World Cancer Day’s call to act for a cancer-free world: what will you pledge to help reduce the global burden of disease?

Marking January’s Cervical Cancer Awareness Month: Ana Oaknin on actions and advances against this disease

21/01/2020|Comments Off on Marking January’s Cervical Cancer Awareness Month: Ana Oaknin on actions and advances against this disease

PI3K blockade in HR-positive breast cancer: the ringing in of a more precise and potent clinical future

09/01/2020|Comments Off on PI3K blockade in HR-positive breast cancer: the ringing in of a more precise and potent clinical future

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2018

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS